Macclesfield-based Spectrum Ophthalmics has set its sights on growth during 2023.
Operating across the UK, the leading independent ophthalmic provider is aiming to increase annual turnover by more than 15%, adding more products to its comprehensive portfolio and expanding its experienced sales team.
Well known for advancing ophthalmic technology with cutting-edge products, support and care solutions, Spectrum works with both the NHS and private sector helping surgeons, optometrists and ophthalmologists deliver the best possible care for their patients.
Focussed on becoming the go-to provider in the sector, the fast-growing company has launched a number of new products including a dynamic operating chair, premium intraocular lenses and range of dry eye solutions aimed at meeting new needs from both b2b and b2c user groups.
It is one year since the company became part of pan-European healthcare brand AddVision. Managing director at Spectrum Ophthalmics, David Killengray, commented: “At some point in our lifetime, most of us will experience impaired vision affecting the day-to-day quality of our lives. At Spectrum, we are committed to providing eyecare specialists with the absolute best ophthalmic products and solutions that enable them to be more successful and help more patients to enjoy better vision.
“Over the next 12 months we will continue to invest in our product range, unique support solutions and experienced team to provide ophthalmologists with the confidence to deliver the best eyecare solutions, treatments, advice and aftercare for their patients.”
Based in Macclesfield, Spectrum Ophthalmics is a leading provider of ophthalmic products, equipment and solutions that help advance ophthalmic technology and services within the UK. From Premium IOLS to Dry Eye Solutions and Diagnostic Technology, Spectrum is known for superior quality and unrelenting passion with the ultimate aim of bringing greater vision to everyone